Amerisource Health Services LLC 2024-07-17 Health serious FDA
Health · FDA · Recall #FDA-D-0590-2024
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets… Recall
Issued July 17, 2024 · Amerisource Health Services LLC
In July 2024, Amerisource Health Services LLC recalled the buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specifications; the product is dissolving faster than the specified limits.
What you should do
- 1 Stop using buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amerisource Health Services LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amerisource Health Services LLC
- Category
- Health
- Recall date
- July 17, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0590-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Amerisource Health Services LLC has 20 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.